Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-28T08:00:58.622Z Has data issue: false hasContentIssue false
  • English
  • Français

Subjective well-being with antipsychotic treatment

Published online by Cambridge University Press:  24 June 2014

R. Köhler ,
Jiri Masopust  and
Jan Libiger
R. Köhler
Affiliation:
Charles University in Prague, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Department of Psychiatry, Hradec Králové, Czech Republic
Jiri Masopust
Affiliation:
Charles University in Prague, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Department of Psychiatry, Hradec Králové, Czech Republic
Jan Libiger
Affiliation:
Charles University in Prague, Faculty of Medicine in Hradec Králové, and University Hospital Hradec Králové, Department of Psychiatry, Hradec Králové, Czech Republic
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Inpc Young Psychiatrists Programme
Information
Acta Neuropsychiatrica , Volume 21 , Issue S2: Special Issue: Abstracts of 49th Neuropsychiatric Pula Congress, 17-20 June 2009, Pula, Croatia , June 2009 , pp. 65
Copyright
Copyright © 2009 John Wiley & Sons A/S

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References:

1.Awad, AG, Voruganti, LN.Neuroleptic dysphoria: revisiting the concept 50 years later. Acta Psychiatr Scand Suppl 2005;427:6–13.CrossRefGoogle Scholar
2.Fleischhacker, WW, Oehl, MAet al.Factors influencing compliance in schizophrenia patients. J Clin Psychiatry 2003;64(Suppl. 16):10–13.Google ScholarPubMed
3.Hogan, TP, Awad, AGet al.A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 1983;13:177–183.CrossRefGoogle ScholarPubMed
4.Hogan, TP, Awad, AG.Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 1992;22:347–352.CrossRefGoogle ScholarPubMed
5.Libiger, J. Neuroleptická dysforie v éře antipsychotik: nové otázky. Psychiatrie 2004;8(Suppl. 1):25.Google Scholar
6.Naber, D, Karow, Aet al.Subjective well-being under neuroleptic treatment and its relevance for compliance. Acta Psychiatricac Scand Suppl 2005;427:29–34.CrossRefGoogle Scholar
7.Naber, D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995;10(Suppl. 3):133–138.Google ScholarPubMed
8.Švestka, J, Bitter, I.Nonadherence to antipsychotic treatment in patients with schizophrenic disorders. Neuroendocrinol Lett 2007;28(Suppl. 1):95–116.Google ScholarPubMed
9.Van Putten, T, May, PRAet al.Subjective response to antipsychotic drugs. Arch Gen Psychiatry 1981;38:187–190.CrossRefGoogle ScholarPubMed
10.Van Putten, T, May, PRAet al.Akathisia with haloperidol and thiothixene. Arch gen Psychiatry 1984;41:1036–1039.CrossRefGoogle ScholarPubMed